StockComparison Logo
vs

RLMD vs EHAB

Comparison between Relmada Therapeutics Inc (RLMD, Company) and Enhabit, Inc. (EHAB, Company).

Both RLMD and EHAB are from the Healthcare sector.

RLMD vs EHAB - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
RLMD
$706M
Winner
EHAB
$707M
Max Drawdown
RLMD
99.66%
Winner
EHAB
71.33%
Sharpe Ratio
Winner
RLMD
2.36
EHAB
0.76
5Y Beta
RLMD
0.84
EHAB
N/A
Industry
RLMD
Biotechnology
EHAB
Medical Care Facilities
P/E Ratio
Winner
RLMD
-6.39
EHAB
13.15
Forward P/E
RLMD
N/A
EHAB
23.75
5Y EPS CAGR
RLMD
-0.59%
EHAB
N/A
Debt to Equity
RLMD
0.00%
EHAB
0.00%
Free Cash Flow Yield
RLMD
-6.06%
Winner
EHAB
11.45%

RLMD vs EHAB - Historical Returns

Returns include dividend reinvestment.

1M
Winner
RLMD
+6.15%
EHAB
-1.00%
3M
RLMD
+8.37%
Winner
EHAB
+23.66%
6M
RLMD
+62.17%
Winner
EHAB
+70.58%
1Y
Winner
RLMD
+861.57%
EHAB
+30.43%
5Y(CAGR)
RLMD
-26.28%
EHAB
N/A
10Y(CAGR)
RLMD
-4.83%
EHAB
N/A
Max(CAGR)
RLMD
-17.11%
Winner
EHAB
-12.11%

RLMD vs EHAB - Annual Returns (2014 - 2026)

Returns include dividend reinvestment.

YearRLMDEHAB
2026+54.00%+51.82%
2025+973.09%+18.97%
2024-88.10%-23.13%
2023+23.21%-20.51%
2022-85.26%-42.13%
2021-31.69%N/A
2020-17.98%N/A
2019+747.83%N/A
2018+64.29%N/A
2017-31.82%N/A
2016-56.40%N/A
2015-84.13%N/A
2014+2.65%N/A

RLMD vs EHAB Drawdown Comparison

The maximum drawdown for RLMD was -99.66%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The maximum drawdown for EHAB was -71.33%, occurring on Aug 1, 2025. This drawdown has not yet recovered.

The current RLMD drawdown is -90.95%. The current EHAB drawdown is -39.31%.

RankRLMDEHAB
#1-99.66%
Mar 16, 2015 - Apr 8, 2025
-71.33%
Jul 1, 2022 - Aug 1, 2025
#2-30.17%
Oct 31, 2014 - Mar 16, 2015
N/A
#3-3.23%
Oct 10, 2014 - Oct 29, 2014
N/A

Correlation

Correlation between RLMD and EHAB is 0.56 which considered as a moderate positive correlation - the stocks show some tendency to move together.

0.56
-101

Select Stocks to Compare